CEBPA Model Recreates RTK–RAS Leukemic Evolution
University of Cambridge and Wellcome Sanger Institute researchers reported an immunocompetent, stepwise model of myeloid-neoplasm evolution. A patient-derived CEBPA N321D mutation created a long-lived premalignant state in Hoxb8-FL murine progenitors; every primary recipient developed…
